Structures by: Sitkowski J.
Total: 15
C19H24.5N2O7.5
C19H24.5N2O7.5
Org. Biomol. Chem. (2003) 1, 20 3578-3585
a=6.8220(10)Å b=23.501(5)Å c=23.730(5)Å
α=90.00° β=90.00° γ=90.00°
4(C30H52Cl2N8O2RuS2),2(CH4O),CH8O2
4(C30H52Cl2N8O2RuS2),2(CH4O),CH8O2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1207-1219
a=33.4606(14)Å b=17.0002(4)Å c=17.9715(9)Å
α=90° β=120.104(6)° γ=90°
C22H36Cl2N8O2RuS2
C22H36Cl2N8O2RuS2
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1207-1219
a=8.7701(7)Å b=21.7923(15)Å c=15.5674(10)Å
α=90° β=99.426(7)° γ=90°
2(C16H32Cl2N4O3RuS3),CH4O
2(C16H32Cl2N4O3RuS3),CH4O
Dalton transactions (Cambridge, England : 2003) (2020) 49, 4 1207-1219
a=14.7951(4)Å b=11.7116(3)Å c=15.5540(4)Å
α=90° β=105.289(3)° γ=90°
C7H15NO2S
C7H15NO2S
New J. Chem. (2004) 28, 12 1562-1567
a=5.3858(3)Å b=13.3905(9)Å c=13.4835(6)Å
α=90.00° β=96.434(9)° γ=90.00°
C9H17NO2S
C9H17NO2S
New J. Chem. (2004) 28, 12 1562-1567
a=5.764(5)Å b=16.888(12)Å c=6.447(4)Å
α=90.00° β=115.20(7)° γ=90.00°
C20H28Cl2N8Pt
C20H28Cl2N8Pt
New J. Chem. (2017)
a=10.5079(3)Å b=12.9149(4)Å c=19.0193(7)Å
α=90° β=104.295(4)° γ=90°
C12H20Cl2N4OPtS
C12H20Cl2N4OPtS
New J. Chem. (2017)
a=13.0528(4)Å b=10.3031(3)Å c=13.9763(4)Å
α=90° β=99.763(3)° γ=90°
C10H17Cl2N5Pt
C10H17Cl2N5Pt
New J. Chem. (2017)
a=13.983(4)Å b=7.6739(11)Å c=15.073(4)Å
α=90° β=116.36(4)° γ=90°
C27H43Cl2N8O0.5Pd
C27H43Cl2N8O0.5Pd
Journal of the Chemical Society, Dalton Transactions (2000) 6 867
a=10.7430(6)Å b=11.0134(5)Å c=14.1340(6)Å
α=75.342(4)° β=81.431(4)° γ=79.665(4)°
cisPT(II)complexwithmethyl3,4diamino2,3,4,6tetradeoxyalphaLlyxoheksopyranosidewithethanol(2:1)
cisPT(II)complexwithmethyl3,4diamino2,3,4,6tetradeoxyalphaLlyxoheksopyranosidewithethanol(2:1)
Dalton Transactions (2003) 11 2177
a=7.823(2)Å b=7.827(2)Å c=43.999(9)Å
α=90.00° β=90.00° γ=90.00°
cisPd(II)complexwithmethyl3,4diamino2,3,4,6tetradeoxyalphaLlyxoheksopyranosidewithethanol(2:1)
cisPd(II)complexwithmethyl3,4diamino2,3,4,6tetradeoxyalphaLlyxoheksopyranosidewithethanol(2:1)
Dalton Transactions (2003) 11 2177
a=7.714(2)Å b=7.718(2)Å c=43.528(9)Å
α=90.00° β=90.00° γ=90.00°
cisPd(II)complexwithmethyl3,4diamino2,3,4,6teradeoxyalphaLlyxohexopyranosidewithwather(1:1)
cisPd(II)complexwithmethyl3,4diamino2,3,4,6teradeoxyalphaLlyxohexopyranosidewithwather(1:1)
Dalton Transactions (2003) 11 2177
a=12.345(2)Å b=28.136(6)Å c=7.734(2)Å
α=90.00° β=90.00° γ=90.00°
Dichlorobispyridazinezinc(II)
C8H8Cl2N4Zn
Acta Crystallographica Section E (2004) 60, 9 m1270-m1272
a=8.0330(10)Å b=17.034(2)Å c=8.5310(10)Å
α=90.00° β=96.090(10)° γ=90.00°